Washington Board Of Pharmacy Collaborative Practice Agreement
Meetings with pharmacists and pharmacists` associations prior to the development of SKC-APC`s CDTA toolkit helped define the types of information and materials needed to support effective pharmacy-public health partnerships. SKC-APC hosted a pharmaceutical leadership summit that brought together 35 local organizations such as public health. commercial, independent, hospital and ethnic pharmacies; and medical services. The CPA has also established an advisory committee on pharmacy operations to discuss how to involve pharmacies more in the event of a public health emergency. These activities have established long-term partnerships between public health organizations and pharmacy, and discussions have provided valuable information on how CD-As could be a viable strategy to ensure the speed and reliability of the delivery of medicines in the event of a disaster. The guidelines and legal requirements for the constitution of the CPA are defined on the basis of the state.  The federal government approved the CPAs in 1995.  Washington was the first state to pass laws allowing formal formation of CPAs. In 1979, Washington changed the practice of pharmaceutical requirements that provide for the formation of “collaborative drug therapy agreements.” [Citation required] Since February 2016, 48 states and Washington D.C have passed laws that allow the availability of CPAs.  The only two states that do not allow cpAs to be made available are Alabama and Delaware.
 Alabama pharmacists hoped that a CPA law, House Bill 494, would be passed in 2015.  The bill was introduced by Alabama House Of Representatives Representative Ron Johnson, but died in committee.  The CDTA toolkit is quite large and is intended to serve as a public health guide throughout the process of developing agreements with pharmacies. To this end, it contains numerous documents and guidelines for recording the stages of the development of a CDTA or a Memorandum of Understanding indicating the role of pharmacies in the event of a disaster. The toolkit also calls on local health authorities to develop strategies with pharmacists that clearly define how medicines and vaccines are distributed in an emergency. Specific instruments include: Arkansan CPs apply to individual pharmacists, practitioners who are “authorized to prescribe drugs” and patients. The specific disease stipulates that pharmacists administer, with indicated medications that the pharmacist can use are necessary. Pharmacists are required to document their interventions for discussion with the collaborative practitioner and must keep these records for at least 2 years after the date of registration.  A cooperation agreement can be referred to as a consultation agreement, a physician-pharmacist agreement, a permanent order or a protocol or a doctor`s delegation. A Collaborative Practice Agreement (CPA) is a legal document in the United States that establishes a legal relationship between clinical pharmacists and cooperating physicians, which allows pharmacists to participate in the collaborative management of drug therapy (CDTM). In the keynote address at the 2013 APH annual meeting, Reid Blackwelder, president of the American Academy of Family Physics (AAFP), called for a “collaborative vision of health.”  In 2015, the American College of Clinical Pharmacy (ACCP) published an updated white paper on the management of collaborative drug therapy.
Categorised as: 未分类